Taiwan - Delayed Quote TWD

Lung Ming Green Energy Technology Engineering Co., Ltd. (3018.TW)

20.10

+0.20

+(1.01%)

At close: 1:20:06 PM GMT+8

Trump-Musk fight reveals fragility of relationship between Silicon Valley and White House

The falling out between President Trump and Elon Musk is just the latest reminder that the relationship between the new White House and the titans of technology has turned out to be complicated.

Yahoo Finance 17 hours ago

MSFT

AMZN

NVDA
Sarepta Therapeutics Plummets 43% After A Second Gene Therapy Recipient Dies

Sarepta stock plummeted Monday after the company said a second patient died following treatment with its gene therapy, Elevidys.

Investor's Business Daily 34 minutes ago

SRPT
Meta stock climbs after announcing Whatsapp advertising plans

Investing.com-- Meta Platforms (NASDAQ:META) stock climbed 2.8% in pre-market trading after the social media giant announced plans to introduce advertising on WhatsApp for the first time, potentially opening a significant new revenue stream.

Investing.com 36 minutes ago

META
Nuclear-Related Stocks Surge. This Stock Has Soared 195% Since Sam Altman Left.

Nuclear stocks and uranium-related plays jumped Monday, continuing to ride the tailwind since President Donald Trump signed nuclear energy executive orders.

Investor's Business Daily 39 minutes ago

SMR

OKLO

BWXT
Meta Stock Gets Price Target Hike As Lower Tariffs Allow 'Better-Than-Feared' Ad Outlook

Meta stock could rally further as easing tariffs allow or a better ad outlook, according to Oppenheimer.

Investor's Business Daily 40 minutes ago

META
Meta Platforms to ’unlock new business with AI’ - Oppenheimer raises price target

Investing.com -- Oppenheimer analysts raised their price target for Outperform-rated Meta Platforms (NASDAQ:META) shares to $775 from $665 in a note Monday, citing a “better than feared” macro and advertising environment.

Investing.com 50 minutes ago

META
Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

Supernus Pharmaceuticals agreed Monday to buy beleaguered biotech Sage Therapeutics in a deal worth up to $561 million.

Investor's Business Daily 1 hour ago

SAGE

SUPN

BIIB
Sarepta down analysts flag risks after second Elevidys-linked death

Investing.com -- BMO Capital and Piper Sandler downgraded Sarepta Therapeutics (NASDAQ:SRPT) after the company reported a second death linked to its gene therapy Elevidys in a non-ambulatory Duchenne muscular dystrophy (DMD) patient.Shares of the company are down around 35% in premarket trading.

Investing.com 1 hour ago

SRPT
EchoStar Soars 43% As Trump Urges FCC To Settle Dispute

EchoStar stock soars on reports that President Trump urged the company, FCC to reach a deal regarding spectrum licenses.

Investor's Business Daily 1 hour ago

SATS
These Stocks Are Moving the Most Today: Sarepta, Tesla, U.S. Steel, Victoria’s Secret, Roku, Lennar, and More

Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of the death of a second patient from acute liver failure.

Barrons.com 1 hour ago

LEN-B

X

TSLA
Crypto group Tron to go public in US via reverse-merger with SRM

Hong Kong-based crypto entrepreneur Justin Sun's blockchain group Tron will go public in the United States in a reverse merger with SRM Entertainment, the companies said on Monday.

Reuters 1 hour ago

SRM
Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

Palantir is benefiting from AI, but its shares sport a rich valuation today. Nvidia is dominating the AI processor market, and demand hasn't slowed. Microsoft made early moves into AI that are already paying off.

Motley Fool 1 hour ago

PLTR

NVDA

MSFT
AMD (AMD) Unveils MI355 AI Chips; Eyes $500B+ Market to Challenge Nvidia

CEO Lisa Su says new processors beat Nvidia's top chips on speed and price

GuruFocus.com 1 hour ago

AMD

NVDA
Sonim Technologies Confirms Receipt of Non-Binding Unsolicited Indication of Interest

San Diego, California--(Newsfile Corp. - June 16, 2025) - The Special Committee of the Board of Directors (the "Special Committee") of Sonim Technologies, Inc. (NASDAQ: SONM), formed to oversee the Company's ongoing strategic alternatives process, today confirmed receipt of an unsolicited indication of interest issued by DOOGEE on June 9, 2025 in the form of a press release, to acquire all outstanding shares of Sonim for $3.60 per share in cash. The Special Committee ...

Newsfile 1 hour ago

SONM
Palantir Price Target Raised to $155 on 'Explosive' AI Potential

Loop Capital Lifts Palantir Target to $155 After CFO Meeting

GuruFocus.com 1 hour ago

PLTR
TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S.

Korea Zinc Co., Ltd., (Korea Zinc) will make a strategic equity investment in TMC of $85.2 million in exchange for 19.6 million common shares at the last market closing price of $4.34 per shareInvestment includes a three-year warrant to purchase 6.9 million common shares (0.35 warrant shares for every 1 initial common share) with an exercise price of $7.00 per share, and a participation right to subscribe for future offerings of TMC equity for Korea Zinc to maintain its ownership of common share

GlobeNewswire 1 hour ago

TMC

TMCWW
AMD Fails to Impress Wall Street, But Cowen Sees AI Breakthroughs

OpenAI, Meta Back AMD AI Chips; Cowen Says 'Still in the Game'

GuruFocus.com 1 hour ago

AMD
Roku stock surges on Amazon Ads partnership

Investing.com -- Roku shares surged 9.8% premarket on Monday after the company announced an exclusive partnership with Amazon (NASDAQ:AMZN) Ads, creating what the firms describe as the “largest authenticated Connected TV (CTV) footprint in the U.S.”

Investing.com 2 hours ago

AMZN

ROKU

DIS
Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.

Supernus Pharmaceuticals signed a definitive agreement to acquire fellow biopharmaceutical company Sage Therapeutics for $8.50 a share in a deal worth an initial $561 million. Sage stock closed last Friday at $6.60 a share, and was up 36% to $9.13 in premarket trading Monday after the deal was announced. The main draw of the deal for Supernus is Sage’s drug Zurzuvae, the first and only oral medication approved by the Food and Drug Administration for treatment of postpartum depression.

Barrons.com 2 hours ago

SAGE

SUPN
Sarepta Stock Plunges After Death of Second Patient Receiving Its Gene Therapy

A second patient receiving its experimental gene therapy Elevidys has died from liver failure, raising serious questions on the drug’s outlook.

Barrons.com 2 hours ago

SRPT

ROG.SW

Performance Overview

Return	3018.TW	TSEC CAPITALIZATION WEIGHTED ST (^TWII)
YTD	-27.57%	-4.28%
1-Year	+31.80%	-2.02%
3-Year	-19.60%	+39.22%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Lung Ming Green Energy Technology Engineering Co., Ltd. (3018.TW)

Related News

Trump-Musk fight reveals fragility of relationship between Silicon Valley and White House

Sarepta Therapeutics Plummets 43% After A Second Gene Therapy Recipient Dies

Meta stock climbs after announcing Whatsapp advertising plans

Nuclear-Related Stocks Surge. This Stock Has Soared 195% Since Sam Altman Left.

Meta Stock Gets Price Target Hike As Lower Tariffs Allow 'Better-Than-Feared' Ad Outlook

Meta Platforms to ’unlock new business with AI’ - Oppenheimer raises price target

Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

Sarepta down analysts flag risks after second Elevidys-linked death

EchoStar Soars 43% As Trump Urges FCC To Settle Dispute

These Stocks Are Moving the Most Today: Sarepta, Tesla, U.S. Steel, Victoria’s Secret, Roku, Lennar, and More

Crypto group Tron to go public in US via reverse-merger with SRM

Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

AMD (AMD) Unveils MI355 AI Chips; Eyes $500B+ Market to Challenge Nvidia

Sonim Technologies Confirms Receipt of Non-Binding Unsolicited Indication of Interest

Palantir Price Target Raised to $155 on 'Explosive' AI Potential

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S.

AMD Fails to Impress Wall Street, But Cowen Sees AI Breakthroughs

Roku stock surges on Amazon Ads partnership

Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.

Sarepta Stock Plunges After Death of Second Patient Receiving Its Gene Therapy

Performance Overview